Protea Biosciences Group, Inc. - FORM 10-K - EX-32.1 - February 23, 2011
| Attached files | ||||||
| File | Filename | |||||
|---|---|---|---|---|---|---|
| 10-K - Protea Biosciences Group, Inc. | v210908_10k.htm | |||||
| EX-32.2 - Protea Biosciences Group, Inc. | v210908_ex32-2.htm | |||||
| EX-31.1 - Protea Biosciences Group, Inc. | v210908_ex31-1.htm | |||||
| EX-31.2 - Protea Biosciences Group, Inc. | v210908_ex31-2.htm | |||||
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of
SRKP 5, Inc. (the "Company") on Form 10-K for the fiscal year ended December 31,
2010 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Richard A. Rappaport, certify, pursuant to 18 U.S.C. ss.
1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to
my knowledge:
(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
| /s/ Richard A. Rappaport | ||
|
Richard
A. Rappaport
Principal
Executive Officer
February
22, 2011
|
User Contributions:
Comment about this document or add new information about this topic:
This web site and associated pages are not associated with, endorsed by, or sponsored by Protea Biosciences Group, Inc. and has no official or unofficial affiliation with Protea Biosciences Group, Inc.
Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
